251 related articles for article (PubMed ID: 10231079)
1. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.
Richter A; Brandeau ML; Owens DK
Med Decis Making; 1999; 19(2):167-79. PubMed ID: 10231079
[TBL] [Abstract][Full Text] [Related]
2. Optimal investment in a portfolio of HIV prevention programs.
Zaric GS; Brandeau ML
Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Alistar SS; Owens DK; Brandeau ML
PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
[TBL] [Abstract][Full Text] [Related]
4. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.
Wilson AR; Kahn JG
J Urban Health; 2003 Sep; 80(3):465-81. PubMed ID: 12930884
[TBL] [Abstract][Full Text] [Related]
5. Prevention of HIV infection in drug abusers: a cost analysis.
Gorsky RD; MacGowan RJ; Swanson NM; DelGado BP
Prev Med; 1995 Jan; 24(1):3-8. PubMed ID: 7740013
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
7. A model for allocating CDC's HIV prevention resources in the United States.
Lasry A; Sansom SL; Hicks KA; Uzunangelov V
Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
[TBL] [Abstract][Full Text] [Related]
8. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
9. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the prevention of HIV infection among and from injecting drug users.
Wodak A; Des Jarlais DC
Bull Narc; 1993; 45(1):47-60. PubMed ID: 8305906
[TBL] [Abstract][Full Text] [Related]
11. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
Weiss SH; Weston CB; Quirinale J
AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
[TBL] [Abstract][Full Text] [Related]
12. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
13. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
14. Value for money in drug treatment: economic evaluation of prison methadone.
Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
[TBL] [Abstract][Full Text] [Related]
15. The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.
Raboud JM; Boily MC; Rajeswaran J; O'Shaughnessy MV; Schechter MT
J Urban Health; 2003 Jun; 80(2):302-20. PubMed ID: 12791806
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study.
Wammes JJ; Siregar AY; Hidayat T; Raya RP; van Crevel R; van der Ven AJ; Baltussen R
Int J Drug Policy; 2012 Sep; 23(5):358-64. PubMed ID: 22884538
[TBL] [Abstract][Full Text] [Related]
17. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.
Rothman J; Rudnick D; Slifer M; Agins B; Heiner K; Birkhead G
J Urban Health; 2007 Mar; 84(2):226-42. PubMed ID: 17216572
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations.
Lampinen TM
NIDA Res Monogr; 1991; 113():114-28. PubMed ID: 1762635
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
[TBL] [Abstract][Full Text] [Related]
20. HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(27):634-6. PubMed ID: 12855944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
